Date published: 2026-5-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

3,5-Diiodothyropropionic acid (CAS 1158-10-7)

5.0(1)
Write a reviewAsk a question

See product citations (4)

Alternate Names:
3,5-Diiodo-4-(4-hydroxyphenoxy)hydrocinnamic acid; DITPA
Application:
3,5-Diiodothyropropionic acid is an ionotropic analog of L-thyroxine
CAS Number:
1158-10-7
Molecular Weight:
510.06
Molecular Formula:
C15H12I2O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

3,5-Diiodothyropropionic acid is a compound that functions as a thyroid hormone analog in experimental applications. It acts by binding to thyroid hormone receptors and modulating gene expression, thereby influencing cellular metabolism and growth. 3,5-Diiodothyropropionic acid exerts its mode of action by interacting with nuclear receptors, leading to the regulation of target genes involved in various physiological processes. Through its molecular interactions, 3,5-Diiodothyropropionic acid can influence the transcription of genes related to metabolism, development, and homeostasis. Its role in experimental research involves understanding the molecular mechanisms underlying thyroid hormone signaling and its impact on cellular function. This compound may serve useful for investigating the specific effects of thyroid hormone analogs on gene expression and cellular processes, contributing to a deeper understanding of thyroid hormone function at the molecular level.


3,5-Diiodothyropropionic acid (CAS 1158-10-7) References

  1. Prevention of abnormal sarcoplasmic reticulum calcium transport and protein expression in post-infarction heart failure using 3, 5-diiodothyropropionic acid (DITPA).  |  Pennock, GD., et al. 2000. J Mol Cell Cardiol. 32: 1939-53. PMID: 11040100
  2. Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure.  |  Morkin, E., et al. 2002. Thyroid. 12: 527-33. PMID: 12165118
  3. Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity.  |  Pennock, GD., et al. 1992. J Pharmacol Exp Ther. 263: 163-9. PMID: 1403782
  4. Effects of thyroid hormone on the cardiovascular system.  |  Fazio, S., et al. 2004. Recent Prog Horm Res. 59: 31-50. PMID: 14749496
  5. DITPA stimulates arteriolar growth and modifies myocardial postinfarction remodeling.  |  Zheng, W., et al. 2004. Am J Physiol Heart Circ Physiol. 286: H1994-2000. PMID: 15072976
  6. Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects.  |  Morkin, E., et al. 2004. J Mol Cell Cardiol. 37: 1137-46. PMID: 15572044
  7. Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated.  |  Mousa, SA., et al. 2006. Endocrinology. 147: 1602-7. PMID: 16384862
  8. Thyroid hormones and 3,5-diiodothyropropionic acid: new keys for new locks.  |  Yen, PM. 2006. Endocrinology. 147: 1598-601. PMID: 16543378
  9. A phosphorimager-based filter binding thyroid hormone receptor competition assay for chemical screening.  |  Chapo, J., et al. 2007. J Pharmacol Toxicol Methods. 56: 28-33. PMID: 17276701
  10. Regulation of gene expression in rats with heart failure treated with the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) and the combination of DITPA and captopril.  |  Maitra, N., et al. 2007. J Cardiovasc Pharmacol. 50: 526-34. PMID: 18030062
  11. Thyroid hormone analog 3,5-diiodothyropropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function.  |  Liu, Y., et al. 2009. Am J Physiol Heart Circ Physiol. 296: H1551-7. PMID: 19286941
  12. Diiodothyropropionic acid: WO2008106213.  |  Raval, S. 2010. Expert Opin Ther Pat. 20: 593-6. PMID: 20192904
  13. Letter by Pingitore et al regarding article, 'DITPA (3,5-diiodothyropropionic acid), a thyroid hormone analog to treat heart failure: phase II trial Veterans Affairs cooperative study'.  |  Pingitore, A., et al. 2010. Circulation. 121: e240; author reply e241. PMID: 20231540
  14. Selective thyroid hormone receptor modulators.  |  Raparti, G., et al. 2013. Indian J Endocrinol Metab. 17: 211-8. PMID: 23776891
  15. Combination treatment with captopril and the thyroid hormone analogue 3,5-diiodothyropropionic acid. A new approach to improving left ventricular performance in heart failure.  |  Pennock, GD., et al. 1993. Circulation. 88: 1289-98. PMID: 8353891

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

3,5-Diiodothyropropionic acid, 50 mg

sc-256593
50 mg
$184.00